Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models

Ezeaka Udoka C., Kim Hye Ji J., Laprairie Robert B.

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (86)

  1. Animal Behavior in Psychedelic Research. 2022-10-01 · Expand citations
  2. Effects of the 5-HT receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents. 2022-06-01 · Expand citations
  3. Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice. 2022-06-01 · Expand citations
  4. The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review. 2022-06-01 · Expand citations
  5. Structure-based discovery of nonhallucinogenic psychedelic analogs. 2022-01-28 · Expand citations
  6. Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis. 2022-01-01 · Expand citations
  7. Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism. 2021-11-19 · Expand citations
  8. A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear. 2021-09-21 · Expand citations
  9. Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo. 2021-08-18 · Expand citations
  10. Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice. 2021-04-27 · Expand citations
  11. Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans. 2021-04-22 · Expand citations
  12. Trial of Psilocybin versus Escitalopram for Depression. 2021-04-15 · Expand citations
  13. Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine. 2021-02-03 · Expand citations
  14. Neuropsychological Functioning in Users of Serotonergic Psychedelics - A Systematic Review and Meta-Analysis. 2021-01-01 · Expand citations
  15. The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies. 2021-01-01 · Expand citations
  16. Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse. 2020-07-01 · Expand citations
  17. Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species. 2020-05-01 · Expand citations
  18. Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression. 2020-03-18 · Expand citations
  19. Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat. 2019-08-01 · Expand citations
  20. Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats. 2019-06-01 · Expand citations
  21. DARK Classics in Chemical Neuroscience: Psilocybin. 2018-10-17 · Expand citations
  22. Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats 2018-09-01 · Expand citations
  23. Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression 2017-06-19 · Expand citations
  24. Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression. 2017-01-01 · Expand citations
  25. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens. 2016-08-01 · Expand citations
  26. Psychedelics. 2016-04-01 · Expand citations
  27. Hallucinogenic drugs in pre-Columbian Mesoamerican cultures. 2015-01-01 · Expand citations
  28. The Effect of Psilocin on Memory Acquisition, Retrieval, and Consolidation in the Rat 2014-05-16 · Expand citations
  29. Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders. 2013-09-01 · Expand citations
  30. Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS 2013-05-01 · Expand citations
  31. Animal models of serotonergic psychedelics. 2013-01-16 · Expand citations
  32. Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice. 2011-11-01 · Expand citations
  33. Determining the pharmacokinetics of psilocin in rat plasma using ultra-performance liquid chromatography coupled with a photodiode array detector after orally administering an extract of Gymnopilus spectabilis 2011-09-01 · Expand citations
  34. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. 2011-09-01 · Expand citations
  35. Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines 2008-10-30 · Expand citations
  36. Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI 2008-07-04 · Expand citations
  37. Psilocybin-induced stimulus control in the rat. 2007-10-01 · Expand citations
  38. The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval. 2007-09-01 · Expand citations
  39. The pharmacology of psilocybin. 2002-10-01 · Expand citations
  40. Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man 1997-06-01 · Expand citations
  41. Severe aggression in rats induced by mescaline but not other hallucinogens. 1979-01-01 · Expand citations
  42. 10.1002/dta.2042
  43. 10.1007/bf02246074
  44. 10.1007/s00213-005-0068-6
  45. 10.1007/s00213-017-4716-4
  46. 10.1007/s00213-018-5118-y
  47. 10.1007/s00216-018-1558-9
  48. 10.1007/s11419-011-0131-4
  49. 10.1016/0091-3057(88)90476-5
  50. 10.1016/0091-3057(89)90431-0
  51. 10.1016/j.cell.2016.12.033
  52. 10.1016/j.cell.2020.08.024
  53. 10.1016/j.neuropharm.2011.02.006
  54. 10.1016/j.pbb.2004.06.012
  55. 10.1016/j.pbb.2005.03.022
  56. 10.1016/j.vascn.2013.12.004
  57. 10.1016/s0091-3057(97)00391-2
  58. 10.1016/s0140-6736(17)32802-7
  59. 10.1016/s0378-4347(01)00386-3
  60. 10.1016/s0893-133x(01)00282-2
  61. 10.1016/s0893-133x(97)00164-4
  62. 10.1021/ac00165a015
  63. 10.1037/0735-7044.110.3.503
  64. 10.1038/s41386-022-01301-9
  65. 10.1038/s41583-020-0367-2
  66. 10.1038/s41594-018-0116-7
  67. 10.1073/pnas.0708862105
  68. 10.1073/pnas.1200506109
  69. 10.1073/pnas.2020705118
  70. 10.1080/03602532.2019.1638931
  71. 10.1089/psymed.2022.0008
  72. 10.1093/jat/20.5.323
  73. 10.1097/fbp.0000000000000183
  74. 10.1111/j.1476-5381.1974.tb08611.x
  75. 10.1111/j.1476-5381.1979.tb07861.x
  76. 10.1126/science.adf0435
  77. 10.1177/026988110001400208
  78. 10.1177/0269881114531666
  79. 10.1177/0269881117725915
  80. 10.1177/02698811221104641
  81. 10.1177/2045125317737264
  82. 10.1523/jneurosci.1665-10.2010
  83. 10.3389/fphar.2018.00994
  84. 10.3389/fphar.2020.602770
  85. 10.4155/bio.14.260
  86. 10.7554/elife.35082

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.